|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
1991-8-1
|
|
pubmed:abstractText |
Inhibitors of the rate-limiting enzyme of cholesterol biosynthesis, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, are now used frequently to treat hypercholesterolemia. We studied the effects of specific inhibition of cholesterol synthesis by one of these agents (pravastatin) on the hepatic metabolism of cholesterol in patients with gallstone disease who were scheduled to undergo cholecystectomy.
|
|
pubmed:language |
ger
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0015-8178
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
20
|
|
pubmed:volume |
109
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
189-94
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:1905265-Adult,
pubmed-meshheading:1905265-Aged,
pubmed-meshheading:1905265-Cholelithiasis,
pubmed-meshheading:1905265-Cholesterol,
pubmed-meshheading:1905265-Female,
pubmed-meshheading:1905265-Heptanoic Acids,
pubmed-meshheading:1905265-Humans,
pubmed-meshheading:1905265-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:1905265-Liver,
pubmed-meshheading:1905265-Male,
pubmed-meshheading:1905265-Middle Aged,
pubmed-meshheading:1905265-Naphthalenes,
pubmed-meshheading:1905265-Pravastatin,
pubmed-meshheading:1905265-Receptors, LDL
|
|
pubmed:year |
1991
|
|
pubmed:articleTitle |
[Effect of pravastatin on hepatic cholesterol metabolism].
|
|
pubmed:affiliation |
Abteilung für Innere Medizin, Universitätsklinik Huddinge/Schweden.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract,
Randomized Controlled Trial
|
